- Grants since 2016
- 239
- Awarded, last 5 years (where amounts are published)
- 34M
- Funded works, last 5 years
- 2 662
- Funded works, all time
- 7 142
Grants
2026–2028 · award
Extending the Use of PARP inhibitors for Triple Negative Breast Cancer Therapy
Alan D'Andrea · Dana-Farber Cancer Institute
2026–2027 · award
Comprehensive genetic diagnosis of HBOC with whole-genome sequencing and standardization of breast and ovarian cancer risk stratification with inclusion of polygenic scores
Judith Balmaña · Vall d'Hebron Institute of Oncology
2026–2028 · award
Boosting response to therapy in relapsed breast cancer
Geoffrey Lindeman · Walter and Eliza Hall Institute of Medical Research
2026–2027 · award
Impact of Exercise on the Immunological Landscape of Benign Breast Tissue in Women with Increased Breast Density
Jennifer Ligibel · Dana-Farber Cancer Institute
2026–2027 · award
Towards BRCA1/BRCA2 population screening: Genomic Analysis of Inherited Breast & Ovarian Cancer in Israeli Women of All Ancestries
Ephrat Levy-Lahad · Shaare Zedek Medical Center
2026–2028 · award
Pathways in Breast Cancer Progression
Lewis Chodosh · The Trustees Of The University Of Pennsylvania
2026–2028 · award
Development and Use of Organoid Models to Elucidate Mechanisms of Tumorigenic Transformation of ER-Positive and ER-Negative Breast Cells
Joan Brugge · Harvard University
2026–2027 · award
Investigating the immunobiology of breast cancer.
Sherene Loi · The University of Melbourne
2026–2027 · award
Receptor Tyrosine Kinases and Breast Cancer Progression
H. Shelton Earp · University of North Carolina at Chapel Hill
2026–2028 · award
Improving Breast Cancer Genetic Risk Assessment and Treatment
James Ford · The Board Of Trustees Of The Leland Stanford Junior University
2026–2028 · award
Predictors of Response and Resistance to Trastuzumab Deruxtecan in HER2-0 Breast Cancer
Ian Krop · Yale University
2026–2028 · award
Cancer Care Delivery and Breast Cancer: Impact and Associated Factors
Mariana Chavez Mac Gregor · The University of Texas MD Anderson Cancer Center
2026–2028 · award
Improving outcomes for molecularly defined high-risk breast cancer subgroups
Christina Curtis · The Board Of Trustees Of The Leland Stanford Junior University
2026–2027 · award
Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancer
Mohamed Bentires-Alj · University of Basel
2026–2027 · award
Microenvironmental regulation of breast cancer metastasis to the brain
Johanna Joyce · University of Lausanne
2026–2027 · award
2-Oxoglutarate Dependent Dioxglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancer
William Kaelin · Dana-Farber Cancer Institute
2026–2027 · award
A novel lineage-tracing mouse model for characterization and targeting of p53-deficient precancerous cells
Jos Jonkers · Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis (the Netherlands Cancer Institute - Nki)
2026–2027 · award
All-of-patient Multimodal and Temporal Foundation Model for Breast Cancer
Faisal Mahmood · Brigham and Women's Hospital
2026–2027 · award
Tumor-Intrinsic and Immune Determinants of Resistance to Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
Joaquin Arribas · Vall d'Hebron Institute of Oncology
2026–2027 · award
Centering patients to improve treatment and outcomes after breast cancer diagnosis
Oluwadamilola Fayanju · Queen's University
2026–2028 · award
Inherited Risk Factors for Breast Cancer
Fergus Couch · Mayo Clinic
2026–2028 · award
Genomic relationships between gynecologic and breast cancers: mechanisms and predictors for targeted therapy efficacy and resistance
Ursula Matulonis · Dana-Farber Cancer Institute
2026–2027 · award
Dual GLP-1/GIP Receptor Agonism for Mitigation of Aromatase Inhibitor-Induced Toxicities: A Pilot Biomarker Study
Sharon Giordano · The University of Texas MD Anderson Cancer Center
2026–2027 · award
Risk factors and molecular mechanisms for estrogen receptor negative breast cancer
Christine Ambrosone · Roswell Park Alliance Foundation
2026–2027 · award
Fluid biopsy in breast cancer patients to characterize cell free and cellular constituents
Peter Kuhn · University of Southern California
2026–2027 · award
A neoadjuvant biomarker approach for estrogen receptor positive breast cancer
Cynthia Ma · Washington University in St. Louis
2026–2028 · award
Precision Antibody Drug Conjugates to target Metastatic Breast Cancer
Aditya Bardia · University of California, Los Angeles
2026–2027 · award
Discovery of New Therapeutic Vulnerabilities in TNBC
Myles Brown · Dana-Farber Cancer Institute
2026–2027 · award
Tackling breast cancer in young women
Cathrin Brisken · Ecole Polytechnique Federale De Lausanne (epfl), Lausanne
2026–2027 · award
Genetic drivers of breast cancer dissemination and distant recurrence
Christopher Li · Fred Hutch Cancer Center
2026–2027 · award
The TOUCH trial: a unique opportunity of studying the biology of HER2+ and ER+ breast cancer
Laura Biganzoli · Hospital of Prato
2026–2028 · award
Targeting breast cancer cells with folate and vitamin C
Lewis Cantley · Dana-Farber Cancer Institute
2026–2028 · award
Childhood and Adolescent Lifestyle, Intermediate Markers, and Breast Cancer Risk
Graham Colditz · Washington University in St. Louis
2026–2027 · award
Translating biomarker dynamics into clinically actionable tools for precision oncology in breast cancer
Luca Gianni · Fondazione Michelangelo Ets
2026–2028 · award
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer
Silvia Formenti · Cornell University
2026–2028 · award
Genome Instability in Breast Cancer
Titia De Lange · Rockefeller University
2026–2028 · award
Microfluidic isolation and characterization of circulating breast cancer cells
Daniel Haber · Massachusetts General Hospital
2026–2028 · award
Understanding and overcoming resistance to anti-cancer therapy
Sarat Chandarlapaty · Memorial Sloan Kettering Cancer Center
2026–2027 · award
Associations between the DNA double-strand break response, hormone exposure, and tissue specificity of BRCA-associated breast cancers
Maria Jasin · Memorial Sloan Kettering Cancer Center
2026–2028 · award
Improving communication about the complexity of modern breast cancer treatment
Lesley Fallowfield · University of Sussex